Who owns LAVA THERAPEUTICS NV?
- Ticker: LVTX
- CUSIP Number: n51517105
Tip: Access positions for across all investors
Analyze quarterly positions in Lava Therapeutics Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lava Therapeutics Nv stock
Who bought or sold LAVA THERAPEUTICS NV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Redmile Group | 2.1M | $3.3M | 0% | Dec 2023 |
|
| Tang Capital Management | 841k | $1.3M | 100% | Dec 2023 |
|
| Bruce & Co | 772k | $1.2M | 0% | Dec 2023 |
|
| Pnc Financial Services | 65k | $103k | 0% | Dec 2023 |
|
| Millennium Management | 28k | $44k | -56% | Dec 2023 |
|
| Citadel Advisors | 22k | $34k | 100% | Dec 2023 |
|
| Pathway Financial Advisors | 14k | $47k | 100% | Mar 2024 |
|
| Simplex Trading | 2.6k | $8.0k | 488% | Mar 2024 |
|
| Cutler | 1.3k | $3.9k | 100% | Mar 2024 |
|
| TSFG | 400.00 | $1.0k | 0% | Mar 2024 |
|
Who sold out of Lava Therapeutics Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Artal Group | Sep 2023 | 200k | $294k |